SEATTLE, WA--(MARKET WIRE)--Mar 12, 2008 -- Targeted Genetics Corporation (NasdaqCM:TGEN - News) announced today that H. Stewart Parker, President and Chief Executive Officer, will present a company overview at the Invest Northwest(TM) Investor and CEO Forum on Tuesday, March 18, at 8:40 a.m. Pacific Time at the Bell Harbor International Conference Center in Seattle, WA.

The presentation will be webcast live and available for replay from the Targeted Genetics website, www.targetedgenetics.com. Links to connect can be found on the Company's homepage under the "Events" section.

About Targeted Genetics

Targeted Genetics Corporation is a biotechnology company committed to the development of innovative targeted molecular therapies for the prevention and treatment of acquired and inherited diseases with significant unmet medical need. Targeted Genetics' proprietary Adeno-Associated Virus (AAV) technology platform allows it to deliver genes that encode proteins to increase gene function or RNAi to decrease or silence gene function. Targeted Genetics' product development efforts target inflammatory arthritis, AIDS prophylaxis, congestive heart failure and Huntington's disease. To learn more about Targeted Genetics, visit Targeted Genetics' website at www.targetedgenetics.com.

     Investor and Media Contacts:
      
     Stacie D. Byars
     WeissComm Partners for
     Targeted Genetics Corporation
     415.946.1072
     Email Contact
      
     Carolyn Wang
     WeissComm Partners
     415.946.1065
     Email Contact